Literature DB >> 8784007

Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material.

M Grabenwöger1, J Sider, F Fitzal, C Zelenka, U Windberger, M Grimm, A Moritz, P Böck, E Wolner.   

Abstract

BACKGROUND: This study was conducted to investigate the impact of the preservation method of bioprosthetic heart valve materials on calcification rates and biocompatibility of the biologic tissue.
METHODS: In subcutaneous rat implants, conventionally preserved bioprosthetic heart valve material was compared with bovine pericardium that was treated with L-glutamic acid to reduce residual glutaraldehyde released from the fixed tissue. Both these methods were compared with bovine pericardium that was stabilized by a dye-mediated photooxidation reaction without glutaraldehyde. Biocompatibility of these biomaterials was tested in vitro using human endothelial cell cultures.
RESULTS: Conventionally preserved bovine pericardium with a high amount of glutaraldehyde incorporated into the tissue resulted in severe calcification 63 days after subcutaneous implantation in rats (165.4 +/- 20 mg Ca2+/g dry weight). Postfixation treatment with L-glutamic acid, which reduces free, unbound aldehyde groups, showed a significant decrease in calcification (89.6 +/- 14 mg Ca2+/g dry weight). Glutaraldehyde-free preservation by dye-mediated photooxidation showed no calcification after 63 days of subcutaneous implantation (1.0 +/- 0.4 mg Ca2+/g dry weight). Regular endothelial cell proliferation was observed on photooxidized and L-glutamic acid-treated tissue, whereas conventionally treated tissue caused endothelial cell death.
CONCLUSIONS: This study underlines the detrimental role of glutaraldehyde in the calcification process of bioprosthetic heart valve materials and emphasizes alternative preservation methods that reduce or avoid the use of glutaraldehyde.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784007

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Fresh Autologous Pericardium to Reconstruct the Pulmonary Valve at the Annulus When Tetralogy of Fallot Requires a Transannular Patch at Midterm.

Authors:  Shantanu Pande; Jugal K Sharma; C R Siddartha; Anubhav Bansal; Surendra K Agarwal; Prabhat Tewari; Aditya Kapoor
Journal:  Tex Heart Inst J       Date:  2016-06-01

2.  Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms.

Authors:  Jeanne M Connolly; Ivan Alferiev; Jocelyn N Clark-Gruel; Naomi Eidelman; Michael Sacks; Elizabeth Palmatory; Allyson Kronsteiner; Suzanne Defelice; Jie Xu; Rachit Ohri; Navneet Narula; Narendra Vyavahare; Robert J Levy
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

3.  The effect of terminal sterilization on structural and biophysical properties of a decellularized collagen-based scaffold; implications for stem cell adhesion.

Authors:  Andrea M Matuska; Peter S McFetridge
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2014-06-03       Impact factor: 3.368

Review 4.  Paediatric nanofibrous bioprosthetic heart valve.

Authors:  Mehrdad Namdari; Babak Negahdari; Ali Eatemadi
Journal:  IET Nanobiotechnol       Date:  2017-08       Impact factor: 1.847

5.  The design and development of a stented tissue mitral and aortic heart valve replacement for human implantation.

Authors:  Murray Legg; Edward Mathews; Ruaan Pelzer
Journal:  Cardiovasc J Afr       Date:  2012-04       Impact factor: 1.167

6.  Surgery for partial atrioventricular septal defect with pulmonary hypertension in an adult dog.

Authors:  Seijirow Goya; Nobuyuki Kanno; Kenji Teshima; Takanori Anndo; Takahiro Fujioka
Journal:  J Vet Med Sci       Date:  2018-06-06       Impact factor: 1.267

7.  Reconstruction of the pulmonary artery by a novel biodegradable conduit engineered with perinatal stem cell-derived vascular smooth muscle cells enables physiological vascular growth in a large animal model of congenital heart disease.

Authors:  Mohamed T Ghorbel; Huidong Jia; Megan M Swim; Dominga Iacobazzi; Ambra Albertario; Carlo Zebele; Delphine Holopherne-Doran; Anthony Hollander; Paolo Madeddu; Massimo Caputo
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

8.  Culture Into Perfusion-Assisted Bioreactor Promotes Valve-Like Tissue Maturation of Recellularized Pericardial Membrane.

Authors:  Francesco Amadeo; Marianna Barbuto; Giacomo Bernava; Nicla Savini; Maura Brioschi; Stefano Rizzi; Cristina Banfi; Gianluca Polvani; Maurizio Pesce
Journal:  Front Cardiovasc Med       Date:  2020-05-12

9.  Mechanical compliance and immunological compatibility of fixative-free decellularized/cryopreserved human pericardium.

Authors:  Maria Cristina Vinci; Giulio Tessitore; Laura Castiglioni; Francesca Prandi; Monica Soncini; Rosaria Santoro; Filippo Consolo; Francesca Colazzo; Barbara Micheli; Luigi Sironi; Gianluca Polvani; Maurizio Pesce
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Tissue response, macrophage phenotype, and intrinsic calcification induced by cardiovascular biomaterials: Can clinical regenerative potential be predicted in a rat subcutaneous implant model?

Authors:  Madeline Cramer; Jordan Chang; Hongshuai Li; Aurelie Serrero; Mohammed El-Kurdi; Martijn Cox; Frederick J Schoen; Stephen F Badylak
Journal:  J Biomed Mater Res A       Date:  2021-07-29       Impact factor: 4.854

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.